Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Raised by Sycomore Asset Management

Sycomore Asset Management lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,945 shares of the medical equipment provider’s stock after purchasing an additional 4,079 shares during the period. Sycomore Asset Management’s holdings in Intuitive Surgical were worth $9,214,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. State Street Corp lifted its stake in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its position in shares of Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. grew its holdings in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after buying an additional 24,183 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $582.98 on Monday. The stock has a market capitalization of $207.65 billion, a price-to-earnings ratio of 90.95, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The business’s fifty day moving average price is $554.85 and its two-hundred day moving average price is $514.38. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Analyst Ratings Changes

Several equities analysts have weighed in on ISRG shares. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Leerink Partners increased their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Bernstein Bank boosted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,671 shares of company stock valued at $3,188,254 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.